Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and safety of polymyxin B in children with carbapenem-resistant gram-negative infections
ChiCTR2100043270Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Jul 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in Carbapenem-resistant Gram-negative bacterial infection (CRGNB), sponsored by Huashan Hospital. Primary endpoint: Plasma polymyxin B concentration. Started Jul 2020; status: recruiting.
02
Drugs
polymyxin B
03
Conditions
Carbapenem-resistant Gram-negative bacterial infection (CRGNB)
Beyond the preview
Go deeper on ChiCTR2100043270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043270.